Synthon Pharmaceuticals, Inc.
🇺🇸United States
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
5
FDA:5
Drug Approvals
Clinical Trials
No trials found
News
Dutch Court Upholds Astellas' Xtandi Formulation Patent Against Synthon Challenge
The District Court of The Hague dismissed Synthon's revocation claim against EP 3 725 778, successfully defending Astellas and Medivation's patent for enzalutamide formulations used in Xtandi for prostate cancer treatment.